Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Shingrix

- PMLiVE

GSK’s Chinese sales hit by scandal, say analysts

Company estimated to have lost a third of its revenues

- PMLiVE

GSK wins anthrax contract from US government

Signs $196m deal for its monoclonal anti-toxin raxibacumab

- PMLiVE

GSK antisense drug fails muscular dystrophy trial

Company and its partner Prosensa suffer setback with drisapersen

- PMLiVE

EMA backs drugs from Novo, Otsuka, AZ, Janssen, GSK

Nine new branded medicines recommended for use in Europe

- PMLiVE

Double asthma approval in Japan lifts SkyePharma

Regulatory wins for company’s commercial partners GSK and Kyorin

- PMLiVE

GSK hands back rights to ChemoCentryx drug

Investigational IBD treatment vercirnon disappoints in phase III

- PMLiVE

FDA guidance clears path for Advair generics

Offers simplified process for potential copies of GSK’s asthma and COPD drug

- PMLiVE

US turns spotlight on GSK bribery allegations

Department of Justice to investigate whether pharma giant contravened foreign corruption act

- PMLiVE

FDA queries safety of GSK’s Anoro for COPD

Adviser questions the drug's cardiovascular profile

- PMLiVE

GSK sells Lucozade and Ribena for £1.35bn

Suntory Beverage & Food acquires consumer brands

- PMLiVE

Setback for GSK as melanoma vaccine misses targets

Cancer immunotherapy disappoints in phase III

- PMLiVE

GSK splits media account between two agencies

GroupM and Omnicom are the winners in GSK’s latest consolidation

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links